AzTrials
AzTrials

Brain ActivityNUMWORDNCT07133230

Neurocognitive Correlates of the Influence of Number Word Syntax on Magnitude Processing

An observational study of Brain Activity, run by Centre Hospitalier St Anne at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Linguistic irregularities in number naming systems, such as the inversion of number words, affect the processing of Arabic numerals. Recently, it has been claimed that there is even a syntactic representation of number words. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Brain Activity
How many people
84 participants
Where
1 siteFrance
Study dates
Sep 2025to 30 Oct 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Adult

Study population: In the experimental phase, 42 adult volunteers (a total of 84), selected according to strict criteria, will undergo an MRI scan, each comprising: - anatomical acquisition, - functional acquisition of activation during a number processing task (Phase 1: two-digit number magnitude comparison; Phase 2: multi-digit mental arithmetic).

Who may be able to join

  • Subject aged 18 to 45 years;
  • Female or male;
  • Right-handed preference;
  • Subject, or legal representative, who has given consent to participate;
  • Native language: French
  • Subject affiliated with a social security system;
Show all 10Show fewer
  • Having signed their consent to participate (and their legal representative if applicable),
  • Subjects have read the information letter and given their free and informed consent;
  • Normal medical, neurological, and neuroradiological examinations
  • For women of childbearing age, be on effective contraception

Who cannot join

  • Not corresponding to the targeted age range;
  • Subject with contraindications to an MRI examination (pacemaker or neurosensory stimulator or implantable defibrillator, cochlear implants, ferromagnetic foreign bodies in the eyes or brain near neural structures, metal prostheses, patient agitation: non-cooperative or agitated patients, minors, claustrophobic subjects, pregnant women, ventriculoperitoneal neurosurgical shunt valves, dental braces);
  • Subject with chronic alcohol or drug use;
  • Abuse or dependence on substances (except nicotine) or toxic substances for more than 5 years or having led to comas (overdoses);
  • Subject with sudden-onset cognitive disorders that could indicate a stroke; a history of head trauma with loss of consciousness for more than 1 hour, or encephalitis;
  • Subject with chronic neurological, psychiatric, endocrine, hepatic, or infectious conditions;
Show all 16Show fewer
  • Subject with a history of major illness (diabetes, chronic lung disease, severe cardiac, metabolic, hematological, endocrine, or immunological disorder, cancer);
  • Subject on medication: taking medications likely to interfere with brain imaging measurements (psychotropics, anxiolytic hypnotics, neuroleptics, anti-Parkinsonians, benzodiazepines, steroidal anti-inflammatories, antiepileptics, central analgesics, and muscle relaxants);
  • Color blindness;
  • Inability to comply with the study for geographical or psychiatric reasons;
  • Tattoo incompatible with MRI;
  • Cerebral palsy;
  • Fine motor skills disorder;
  • Pregnant women at the time of inclusion;
  • Adult subjects under legal protection or unable to give consent (article L.1121-8 of the French Public Health Code) (under guardianship or curatorship);
  • Children and parents under legal protection measures

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • GHU Ste Anne

    Paris, 75014

    Elise KLEIN

Other trials in France

About this study

Linguistic irregularities in number naming systems, such as the inversion of number words, affect the processing of Arabic numerals. Recently, it has been claimed that there is even a syntactic representation of number words. participant investigate the neurofunctional correlates of the syntactic processing of number words by examining different levels of place-value processing in a study with two complementary successive phases (Group 1 and Group 2) in healthy adults. In the first phase with Group 1, participant evaluate the unit-decade compatibility effect (UDCE) in two-digit magnitude comparisons. In the second phase with Group 2, participant investigate the carry-over effect in two-digit addition problems.

Read the detailed description

Selection visit

  • Call for participants for pre-selection
  • Sending of information forms by mail
  • Making an appointment for the inclusion visit at GHU Paris
  • Information on the modalities, constraints and foreseeable risks of the study
  • Collection of informed consent
  • Verification of inclusion/non-inclusion criteria
  • Clinical examination:
  • Verification of medical history and drug treatments
  • Psychiatric pathology
  • Consumption of toxic substances (nicotine, alcohol, cannabis, etc.)
  • Manual lateralization will be assessed by the score on the Edinburgh questionnaire (Oldfield, 1971)
  • Collection of main medical history and concomitant treatments
  • Explanation of study procedures
  • MRI examination
Conditions
Brain Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07133230
Study groupRoleWhat they receive
Participants recruited (phase 1)In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.
Participants recruited (phase 2)In each experimental phase (2 in total), 42 adult volunteers will be recruited (a total of 84 participants), selected based on the following criteria: * Aged 18-45 * Female or male * Right-handed * Signed informed consent * Normal medical, neurological, and neuroradiological examinations * Affiliated with a social security system * For women of childbearing age: under effective contraception; a urine pregnancy test will be administered * MRI examination compatible Participants will be recruited in the Paris region.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurofunctional variables (fMRI)

    the comparison of pairs of incompatible numbers compared to pairs of compatible numbers during the comparison of numbers.

    Measured: Day 1

  2. Structural variables (structural MRI)

    the comparison of problems of addition with and without restraint during mental arithmetic.

    Measured: Day 1

  3. Behavioral variables,

    we compare performance to the post-imaging reading test

    Measured: Day 1

  4. structural variables

    recording of morphological and brain morphometric characteristics.

    Measured: Day 1

Secondary outcomes (2)
  1. Handedness score

    Measuring the lateralization of the hand will allow to recognize, based on the proposed activities, the dominant hand.

    Measured: Day 1

  2. Demographics questionnaire

    this questionnaire which will allow the collection of all the precise information about the participant

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2025
  2. Study startSep 2025 (estimated)
  3. Primary completionOct 2027 (estimated)
  4. Study completion30 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07133230
Sponsor's protocol ID
D24-P010
Acronym
NUMWORD
Status last verified
May 2025
First submitted
12 Jun 2025
Last updated
20 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Activity, run by Centre Hospitalier St Anne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elise Klein (+49 175 2042210‬, elise.klein@u-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurofunctional variables (fMRI) (time frame: Day 1). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in